Method for treating cancer and inflammatory diseases using stem cell- derived extracellular vesicles comprising sirp
AssigneeShiftbio
InventorsGi-Hoon NAM, Gi Beom KIM, Seohyun KIM, Yoon Kyoung KIM, Jae Hyun KIM, Seonghyun KIM
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to a stem cell-derived extracellular vesicle (EV) comprising a signal regulatory protein (SIRP) and a method for preventing or treating cancer and/or inflammatory disease, condition, or symptom by using the stem cell-derived EV.
Claims14
A method for preventing or treating cancer or inflammatory disease, condition, or symptom, the method comprising administering to a subject in need thereof a prophylactically or therapeutically effective amount of stem cell-derived extracellular vesicles (EV) that comprise a signal regulatory protein (SIRP), a fragment of the SIRP, a variant of the SIRP, a fragment of the variant, or a variant of the fragment.
Dependencies are inferred from the claim text.